𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adalimumab for the treatment of fistulas in patients with Crohn's disease

✍ Scribed by Steven N. Fine

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
42 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adalimumab treatment for peristomal pyod
Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease
✍ Naim Alkhouri; Vera Hupertz; Lori Mahajan πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 1 views

PG) is an uncommon neutrophilic dermatosis first described by Brunsting et al in 1930. 1 It is a painful, chronic ulcerating inflammatory skin condition that appears to be immune-mediated. The characteristic lesion begins as small erythematous papules that rapidly spread concentrically, coalesce, an

Adalimumab safety in global clinical tri
Adalimumab safety in global clinical trials of patients with Crohn's disease
✍ Jean-FrΓ©dΓ©ric Colombel; William J. Sandborn; Remo Panaccione; Anne M. Robinson; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 145 KB πŸ‘ 1 views

Background: Adalimumab, a fully human anti-tumor necrosis factor (anti-TNF) monoclonal antibody, is approved for the treatment of Crohn's disease (CD) in adults. We evaluated the overall safety profile of adalimumab in global clinical trials in patients with CD. Patients who participated in these tr

Rarity of fistulas in Crohn's disease of
Rarity of fistulas in Crohn's disease of the jejunum
✍ Dr. James F. Marion; Prem Lachman; Adrian J. Greenstein; David B. Sachar πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 262 KB πŸ‘ 1 views